GAS6/AXL signaling induces mesangial cell proliferation and glomerular hypertrophy in early DKD through the activation of the Akt/mTOR pathway (12, 13), thereby promoting diabetic glomerulopathy. Here, AXL is linked to diabetic kidney disease.